METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer.
Biomedicines
; 11(1)2023 Jan 13.
Article
em En
| MEDLINE
| ID: mdl-36672713
METCAM; Western blot and ELISA; biomarker of prostate cancer; biotinylated antibodies; magnetic beads-enriched array display; magnetic beads-purified serum; nano-gold conjugated antibodies; streptavidin; therapeutic target for prostate cancer; traditional and modified LFIA; tumorigenesis and metastasis driver
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article